BAX Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (3 geg. 2024 @ 23:00):

Stats
Dzisiejszy wolumen	5.54M
Średni wolumen	3.76M
Kapitalizacja rynkowa	18.74B
EPS	$0 ( 2024-05-02 )
Następna data zysków	( $0.670 ) 2024-07-25
Last Dividend	$0.290 ( 2024-02-29 )
Next Dividend	$0 ( N/A )
P/E	-461.12
ATR14	$0.0380 (0.10%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-06	Toth Christopher A.	Buy	119 076	Common Stock, $1 par value
2024-03-06	Stevens Brian	Buy	14 289	Common Stock, $1 par value
2024-03-06	Sonig Alok	Buy	83 353	Common Stock, $1 par value
2024-03-06	Rosenbloom David S.	Buy	53 584	Common Stock, $1 par value
2024-03-06	Rasul Reazur	Buy	83 353	Common Stock, $1 par value

INSIDER POWER
77.27
Last 100 transactions
Buy: 1 860 689 \| Sell: 191 040

Wolumen Korelacja

Długi: -0.07 (neutral)

Krótki: -0.18 (neutral)

Signal:(60.314) Neutral

Baxter International Inc Korelacja

10 Najbardziej pozytywne korelacje
LOCL	0.91
PAK	0.91
RSF	0.905
ZME	0.905
GAZ	0.903
UNG	0.902
GDMA	0.897
UNL	0.892
UBP	0.889
RKLY	0.889

10 Najbardziej negatywne korelacje
FSNB	-0.946
LHC	-0.934
PORT	-0.928
ALCC	-0.927
HWKZ	-0.92
NETC	-0.92
EVE	-0.919
DSAQ	-0.919
JMP	-0.918
CLBR	-0.918

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Baxter International Inc Korelacja - Waluta/Towar

0.15
( neutral )

0.09
( neutral )

0.00
( neutral )

0.30
( neutral )

0.39
( neutral )

0.16
( neutral )

Baxter International Inc Finanse

Annual	2023
Przychody:	$14.81B
Zysk brutto:	$4.98B (33.59 %)
EPS:	$-0.450

FY	2023
Przychody:	$14.81B
Zysk brutto:	$4.98B (33.59 %)
EPS:	$-0.450

FY	2022
Przychody:	$15.11B
Zysk brutto:	$5.40B (35.71 %)
EPS:	$-4.80

FY	2021
Przychody:	$12.78B
Zysk brutto:	$5.11B (39.93 %)
EPS:	$2.52

Financial Reports:

No articles found.

Baxter International Inc Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0.290 (N/A)	$0.290 (N/A)	$0.290 (N/A)	$0.290 (N/A)	$0.290 (N/A)	$0.290 (N/A)	$0.290 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Baxter International Inc Dividend Information - Dividend King

Dividend Sustainability Score: 9.51 - good (95.07%) | Divividend Growth Potential Score: 5.42 - Stable (8.30%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	$0.0142	1982-03-10
Last Dividend	$0.290	2024-02-29
Next Dividend	$0	N/A
Payout Date	2024-04-01
Next Payout Date	N/A
# dividends	150	--
Total Paid Out	$21.30	--
Avg. Dividend % Per Year	1.37%	--
Score	5.29	--
Div. Sustainability Score	9.51
Div.Growth Potential Score	5.42
Div. Directional Score	7.46	--

Next Divdend (Est)
(2024-07-29)

$0.292 Estimate 60.98 %

Dividend Stability

0.98 Excellent

Dividend Score

5.29

Pay Frequency

Quarterly

Yearly Payout

Year	Amount	Yield
1982	$0.0568	1.35%
1983	$0.0692	1.21%
1984	$0.0808	1.41%
1985	$0.0908	2.80%
1986	$0.0988	2.59%
1987	$0.108	2.31%
1988	$0.123	2.14%
1989	$0.138	3.17%
1990	$0.158	2.51%
1991	$0.182	2.70%
1992	$0.217	2.25%
1993	$0.272	3.14%
1994	$0.278	4.20%
1995	$0.301	3.94%
1996	$1.296	11.50%
1997	$0.314	2.85%
1998	$0.315	2.32%
1999	$0.315	1.84%
2000	$1.053	6.32%
2001	$0.316	1.30%
2002	$0.316	1.10%
2003	$0.316	2.03%
2004	$0.316	1.93%
2005	$0.316	1.68%
2006	$0.316	1.52%
2007	$0.392	1.55%
2008	$0.495	1.58%
2009	$0.581	1.94%
2010	$0.642	2.03%
2011	$0.686	2.50%
2012	$0.852	3.10%
2013	$1.042	2.84%
2014	$1.112	2.96%
2015	$0.794	1.99%
2016	$0.505	1.36%
2017	$0.610	1.37%
2018	$0.730	1.09%
2019	$0.850	1.30%
2020	$0.955	1.11%
2021	$1.085	1.35%
2022	$1.150	1.32%
2023	$1.160	2.27%
2024	$0.290	0.75%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for NYSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
LOMA	Dividend Knight	2023-06-30	Quarterly	2	5.23%	8.53
PCF	Dividend King	2023-12-18	Monthly	38	7.05%	8.50
ZTR	Dividend Royal	2024-02-09	Monthly	37	8.35%	8.50
PVL	Dividend King	2023-11-15	Monthly	14	9.37%	8.50
NCV	Dividend Royal	2024-02-09	Monthly	22	7.68%	8.50
JQC	Dividend Royal	2023-11-14	Monthly	22	6.56%	8.50
SCM	Dividend King	2023-12-15	Monthly	13	7.08%	8.50
MTR	Dividend Diamond	2023-10-30	Monthly	39	10.10%	8.50
SBR	Dividend Royal	2023-11-14	Monthly	38	7.74%	8.50
PDI	Dividend Royal	2023-11-10	Monthly	13	7.86%	8.50

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.178	1.500	6.44	9.66	[0 - 0.5]
returnOnAssetsTTM	0.0953	1.200	6.82	8.19	[0 - 0.3]
returnOnEquityTTM	0.350	1.500	7.22	10.00	[0.1 - 1]
payoutRatioTTM	0.166	-1.000	8.34	-8.34	[0 - 1]
currentRatioTTM	1.477	0.800	7.62	6.09	[1 - 3]
quickRatioTTM	0.871	0.800	9.58	7.66	[0.8 - 2.5]
cashRatioTTM	0.475	1.500	8.47	10.00	[0.2 - 2]
debtRatioTTM	0.510	-1.500	1.501	-2.25	[0 - 0.6]
interestCoverageTTM	0.567	1.000	-0.901	-0.901	[3 - 30]
operatingCashFlowPerShareTTM	2.45	2.00	9.18	10.00	[0 - 30]
freeCashFlowPerShareTTM	1.085	2.00	9.46	10.00	[0 - 20]
debtEquityRatioTTM	1.734	-1.500	3.06	-4.60	[0 - 2.5]
grossProfitMarginTTM	0.342	1.000	7.64	7.64	[0.2 - 0.8]
operatingProfitMarginTTM	0.0173	1.000	-1.654	-1.654	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.0880	1.000	-0.622	-0.622	[0.2 - 2]
assetTurnoverTTM	0.536	0.800	9.76	7.81	[0.5 - 2]
Total Score				9.51

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	7.07	1.000	9.39	0	[1 - 100]
returnOnEquityTTM	0.350	2.50	8.21	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	1.085	2.00	9.64	10.00	[0 - 30]
dividendYielPercentageTTM	3.14	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	2.45	2.00	9.18	10.00	[0 - 30]
payoutRatioTTM	0.166	1.500	8.34	-8.34	[0 - 1]
pegRatioTTM	0.0172	1.500	-3.22	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0837	1.000	-0.407	0	[0.1 - 0.5]
Total Score				5.42

Baxter International Inc

Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug platforms, inhaled anesthesia and critical care products and pharmacy compounding services; parenteral nutrition therapies and related products; biological products and medical devices used in surgical procedures for hemostasis, tissue sealing and adhesion prevention; and continuous renal replacement therapies and other organ support therapies focused in the intensive care unit. It also provides connected care solutions, including devices, software, communications, and integration technologies; integrated patient monitoring and diagnostic technologies to help diagnose, treat, and manage a various illness and diseases, including respiratory therapy, cardiology, vision screening, and physical assessment; surgical video technologies, tables, lights, pendants, precision positioning devices and other accessories. In addition, the company offers contracted services to various pharmaceutical and biopharmaceutical companies. Its products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic molecules. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.